341 related articles for article (PubMed ID: 32856005)
1. Grant Report on d-Serine Augmentation of Neuroplasticity-Based Auditory Learning in Schizophrenia
de la Garrigue N; Glasser J; Sehatpour P; Iosifescu DV; Dias E; Carlson M; Shope C; Sobeih T; Choo TH; Wall MM; Kegeles LS; Gangwisch J; Mayer M; Brazis S; De Baun HM; Wolfer S; Bermudez D; Arnold M; Rette D; Meftah AM; Conant M; Lieberman JA; Kantrowitz JT
J Psychiatr Brain Sci; 2020; 5(4):. PubMed ID: 32856005
[TBL] [Abstract][Full Text] [Related]
2. Dose-Dependent Augmentation of Neuroplasticity-Based Auditory Learning in Schizophrenia: A Double-Blind, Placebo-Controlled, Randomized, Target Engagement Clinical Trial of the NMDA Glutamate Receptor Agonist d-serine.
Sehatpour P; Iosifescu DV; De Baun HM; Shope C; Mayer MR; Gangwisch J; Dias E; Sobeih T; Choo TH; Wall MM; Medalia A; Saperstein AM; Kegeles LS; Girgis RR; Carlson M; Kantrowitz JT
Biol Psychiatry; 2023 Jul; 94(2):164-173. PubMed ID: 36958998
[TBL] [Abstract][Full Text] [Related]
3. Augmentation of learning in schizophrenia by D-serine is related to auditory and frontally-generated biomarkers: A randomized, double-blind, placebo-controlled study.
Govani V; Shastry A; Iosifescu D; Govil P; Mayer M; Sobeih T; Choo T; Wall M; Sehatpour P; Kantrowitz J
Res Sq; 2023 May; ():. PubMed ID: 37293030
[TBL] [Abstract][Full Text] [Related]
4. Improvement in mismatch negativity generation during d-serine treatment in schizophrenia: Correlation with symptoms.
Kantrowitz JT; Epstein ML; Lee M; Lehrfeld N; Nolan KA; Shope C; Petkova E; Silipo G; Javitt DC
Schizophr Res; 2018 Jan; 191():70-79. PubMed ID: 28318835
[TBL] [Abstract][Full Text] [Related]
5. Neurophysiological mechanisms of cortical plasticity impairments in schizophrenia and modulation by the NMDA receptor agonist D-serine.
Kantrowitz JT; Epstein ML; Beggel O; Rohrig S; Lehrfeld JM; Revheim N; Lehrfeld NP; Reep J; Parker E; Silipo G; Ahissar M; Javitt DC
Brain; 2016 Dec; 139(Pt 12):3281-3295. PubMed ID: 27913408
[TBL] [Abstract][Full Text] [Related]
6. Auditory System Target Engagement During Plasticity-Based Interventions in Schizophrenia: A Focus on Modulation of N-Methyl-D-Aspartate-Type Glutamate Receptor Function.
Kantrowitz JT; Swerdlow NR; Dunn W; Vinogradov S
Biol Psychiatry Cogn Neurosci Neuroimaging; 2018 Jul; 3(7):581-590. PubMed ID: 29656951
[TBL] [Abstract][Full Text] [Related]
7. N-methyl-d-aspartate-type glutamate receptor modulators and related medications for the enhancement of auditory system plasticity in schizophrenia.
Kantrowitz JT
Schizophr Res; 2019 May; 207():70-79. PubMed ID: 29459050
[TBL] [Abstract][Full Text] [Related]
8. The effects of glycine on auditory mismatch negativity in schizophrenia.
Greenwood LM; Leung S; Michie PT; Green A; Nathan PJ; Fitzgerald P; Johnston P; Solowij N; Kulkarni J; Croft RJ
Schizophr Res; 2018 Jan; 191():61-69. PubMed ID: 28602646
[TBL] [Abstract][Full Text] [Related]
9. Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia.
Hamilton HK; D'Souza DC; Ford JM; Roach BJ; Kort NS; Ahn KH; Bhakta S; Ranganathan M; Mathalon DH
Schizophr Res; 2018 Jan; 191():87-94. PubMed ID: 28711472
[TBL] [Abstract][Full Text] [Related]
10. Rodent Mismatch Negativity/theta Neuro-Oscillatory Response as a Translational Neurophysiological Biomarker for N-Methyl-D-Aspartate Receptor-Based New Treatment Development in Schizophrenia.
Lee M; Balla A; Sershen H; Sehatpour P; Lakatos P; Javitt DC
Neuropsychopharmacology; 2018 Feb; 43(3):571-582. PubMed ID: 28816240
[TBL] [Abstract][Full Text] [Related]
11. The D-amino acid oxidase inhibitor luvadaxistat improves mismatch negativity in patients with schizophrenia in a randomized trial.
O'Donnell P; Dong C; Murthy V; Asgharnejad M; Du X; Summerfelt A; Lu H; Xu L; Wendland JR; Dunayevich E; Buhl DL; Litman R; Hetrick WP; Hong LE; Rosen LB
Neuropsychopharmacology; 2023 Jun; 48(7):1052-1059. PubMed ID: 36928351
[TBL] [Abstract][Full Text] [Related]
12. Behavioral and cognitive effects of the N-methyl-D-aspartate receptor co-agonist D-serine in healthy humans: initial findings.
Levin R; Dor-Abarbanel AE; Edelman S; Durrant AR; Hashimoto K; Javitt DC; Heresco-Levy U
J Psychiatr Res; 2015 Feb; 61():188-95. PubMed ID: 25554623
[TBL] [Abstract][Full Text] [Related]
13. Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia.
Umbricht D; Schmid L; Koller R; Vollenweider FX; Hell D; Javitt DC
Arch Gen Psychiatry; 2000 Dec; 57(12):1139-47. PubMed ID: 11115327
[TBL] [Abstract][Full Text] [Related]
14. Association between increased serum d-serine and cognitive gains induced by intensive cognitive training in schizophrenia.
Panizzutti R; Fisher M; Garrett C; Man WH; Sena W; Madeira C; Vinogradov S
Schizophr Res; 2019 May; 207():63-69. PubMed ID: 29699895
[TBL] [Abstract][Full Text] [Related]
15. Acute effects of Δ
Greenwood LM; Broyd SJ; van Hell HH; Todd J; Jones A; Murray RM; Croft RJ; Michie PT; Solowij N
Psychopharmacology (Berl); 2022 May; 239(5):1409-1424. PubMed ID: 34719731
[TBL] [Abstract][Full Text] [Related]
16. Neurophysiological Effects of Bitopertin in Schizophrenia.
Kantrowitz JT; Nolan KA; Epstein ML; Lehrfeld N; Shope C; Petkova E; Javitt DC
J Clin Psychopharmacol; 2017 Aug; 37(4):447-451. PubMed ID: 28590364
[TBL] [Abstract][Full Text] [Related]
17. Acute high-dose glycine attenuates mismatch negativity (MMN) in healthy human controls.
Leung S; Croft RJ; O'Neill BV; Nathan PJ
Psychopharmacology (Berl); 2008 Feb; 196(3):451-60. PubMed ID: 17952411
[TBL] [Abstract][Full Text] [Related]
18. Effects of Augmenting N-Methyl-D-Aspartate Receptor Signaling on Working Memory and Experience-Dependent Plasticity in Schizophrenia: An Exploratory Study Using Acute d-cycloserine.
Forsyth JK; Bachman P; Mathalon DH; Roach BJ; Ye E; Asarnow RF
Schizophr Bull; 2017 Sep; 43(5):1123-1133. PubMed ID: 28338977
[TBL] [Abstract][Full Text] [Related]
19. NMDA Receptor Antagonist Effects on Speech-Related Mismatch Negativity and Its Underlying Oscillatory and Source Activity in Healthy Humans.
de la Salle S; Shah D; Choueiry J; Bowers H; McIntosh J; Ilivitsky V; Knott V
Front Pharmacol; 2019; 10():455. PubMed ID: 31139075
[TBL] [Abstract][Full Text] [Related]
20. Nicotine, Auditory Sensory Memory, and sustained Attention in a Human Ketamine Model of Schizophrenia: Moderating Influence of a Hallucinatory Trait.
Knott V; Shah D; Millar A; McIntosh J; Fisher D; Blais C; Ilivitsky V
Front Pharmacol; 2012; 3():172. PubMed ID: 23060793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
